Transduction of antisense cyclin D1 using two-step gene transfer inhibits the growth of rat hepatoma cells

Cancer Research

Volumn 61, Issue 12, 2001, Pages 4779-4783

  Uto, H ^a   Ido, A ^a   Moriuchi, A ^a   Onaga, Y ^a   Nagata, K ^a   Onaga, M ^a   Tahara, Y ^a   Hori, T ^a   Hirono, S ^a   Hayashi, K ^a   Tsubouchi, H ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; CYCLIN D1; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CELL GROWTH; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HEPATOMA CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PRIORITY JOURNAL; RAT; VIRUS RECOMBINANT; XENOGRAFT;

ANIMALS; BLOTTING, NORTHERN; CELL DIVISION; CYCLIN D1; DNA, ANTISENSE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; RATS; RATS, WISTAR; RETROVIRIDAE; RNA, MESSENGER; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035874885     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. D-type cyclin-dependent kinase activity in mammalian cells
2. E2F: A link between the Rb tumor-suppressor protein and viral oncogenesis
3. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
4. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma
5. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma
6. Small hyperechoic nodules in chronic liver diseases include hepatocellular carcinomas with low cyclin D1 and Ki-67 expression
7. Expression and prognostic roles of the Gi-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence
8. Therapy of unresectable hepatocellular carcinoma
9. Primary liver cancer in Japan: Clinicopathologic features and results of surgical treatment
10. Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: Tumor multicentricity in cirrhotic liver with hepatitis C
11. Hepatoma-specific gene therapy through retrovirus-mediated and targeted gene transfer using an adenovirus carrying the ecotropic receptor gene
12. Relationship between cellular ATP content and cellular functions of primary cultured rat hepatocytes in hypoxia
13. Cyclin G: A new mammalian cyclin with homology to fission yeast Cig1
14. Improved retroviral vectors for gene transfer and expression
15. Efficient selection for high-expression transfectants with a novel eukaryotic vector
16. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome
17. Isolation and characterization of rat and human glyceraldehydes-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene
18. Antisense c-myc retroviral vector suppresses established human prostate cancer
19. Single stranded DNA as an immunocytochemical marker for apoptotic change of ischemia in the gerbil hippocampus
20. Detection of apoptotic cells in human colorectal cancer by two different in situ methods: Antibody against single-stranded DNA and terminal deoxynucleotidyl transferase-mediated dUTPbiotin nick end-labeling (TUNEL) methods
21. Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma
22. Cyclin DI overexpression and prognosis in colorectal adenocarcinoma
23. Prognostic role of cyclin D1 in non-small cell lung cancer: An immunohistochemical analysis
24. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France
25. p161NK4 is inactivated by extensive CpG methylation in human hepatocellular carcinoma
26. Absence of WAF1 mutations in a variety of human malignancies
27. p27Kipl: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors
28. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells
29. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells
30. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum
31. Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes
32. Retroviral vector-mediated gene transfer of antisense cyclin G1 (cycg1) inhibits proliferation of human osteogenic sarcoma cells
33. Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas
34. Activation of the cyclin Dl gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis
35. Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis
36. Enhancement of retrovirus-mediated gene transduction efficiency by transient overexpression of the amphotropic receptor, GLVR-2
37. Simultaneous up-regulation of viral receptor expression and DNA synthesis is required for increasing efficiency of retroviral hepatic gene transfer